Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer

NCT03900884 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm Female

Interventions

DRUG: Venetoclax
DRUG: Palbociclib
DRUG: Letrozole

Sponsor

Peter MacCallum Cancer Centre, Australia